Abstract:Background Gut ischemia/reperfusion causes the release of damage-associated molecular patterns, leading to acute lung injury and high mortality. Cold-inducible ribonucleic acid-binding protein is a ribonucleic acid chaperon that binds the polyadenylation tail of messenger ribonucleic acid intracellularly. Upon cell stress, cold-inducible ribonucleic acid-binding protein is released, and extracellular cold-inducible ribonucleic acid-binding protein acts as a damage-associated molecular pattern, worsening inflammation. To inhibit extracellular cold-inducible ribonucleic acid-binding protein, we have recently developed an engineered polyadenylation tail named A 12 . Here, we sought to investigate the therapeutic potential of A 12 in gut ischemia/reperfusion-induced acute lung injury. Methods Male C57BL6/J mice underwent superior mesenteric artery occlusion and were treated with intraperitoneal A 12 (0.5 nmol/g body weight) or vehicle at the time of reperfusion. Blood and lungs were collected 4 hours after gut ischemia/reperfusion. Systemic levels of extracellular cold-inducible ribonucleic acid-binding protein, interleukin-6, aspartate transaminase, alanine transaminase, and lactate dehydrogenase were determined. The pulmonary gene expression of cytokines (interleukin-6, interleukin-1β) and chemokines (macrophage-inflammatory protein-2, keratinocyte-derived chemokine) was also assessed. In addition, lung myeloperoxidase, injury score, and cell death were determined. Mice were monitored for 48 hours after gut ischemia/reperfusion for survival assessment. Results Gut ischemia/reperfusion significantly increased the serum extracellular cold-inducible ribonucleic acid-binding protein levels. A 12 treatment markedly reduced the elevated serum interleukin-6, alanine transaminase, aspartate transaminase, and lactate dehydrogenase by 53%, 23%, 23%, and 24%, respectively, in gut ischemia/reperfusion mice. A 12 also significantly decreased cytokine and chemokine messenger ribonucleic acids and myeloperoxidase activity in the lungs of gut ischemia/reperfusion mice. Histological analysis revealed that A 12 attenuated tissue injury and cell death in the lungs of gut ischemia/reperfusion mice. Finally, administration of A 12 markedly improved the survival of gut ischemia/reperfusion mice. Conclusion A 12 , a novel extracellular cold-inducible ribonucleic acid-binding protein inhibitor, diminishes inflammation and mitigates acute lung injury when employed as a treatment during gut ischemia/reperfusion. Hence, the targeted approach toward extracellular cold-inducible ribonucleic acid-binding protein emerges as a promising therapeutic strategy for alleviating gut ischemia/reperfusion-induced acute lung injury.

A Novel Oligonucleotide mRNA Mimic Attenuates Hemorrhage-Induced Acute Lung Injury

Harnessing extracellular cold-inducible RNA binding protein by PS-OMe miR130: A promising shield against hemorrhage-induced lung injury

An engineered poly(A) tail attenuates gut ischemia/reperfusion-induced acute lung injury

Genome-wide Landscape of Mrnas, Micrornas, Lncrnas, and Circrnas in Hemorrhagic Shock-Induced ALI/ARDS in Rats.

A Microsatellite DNA-derived Oligodeoxynucleotide Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting the HMGB1-TLR4-NF-κB Signaling Pathway

Inhibition Of Hypoxia Inducible Factor-1 Alpha Ameliorates Lung Injury Induced By Trauma And Hemorrhagic Shock In Rats

Inhibition of Hypoxia Inducible Factor-1Α Ameliorates Lung Injury Induced by Trauma and Hemorrhagic Shock in Rats

A Synthetic Poly(A) Tail Targeting Extracellular CIRP Inhibits Sepsis

[The Conditional Knockout of CD226 Gene Reduces Acute Lung Injury in Mice with Hemorrhagic Shock].

Protective effect of 8-Gingerol, a potent constituent of ginger, on acute lung injury following hemorrhagic shock in rats

Antisense Oligonucleotide Treatment Enhances The Recovery Of Acute Lung Injury Through Il-10-Secreting M2-Like Macrophage-Induced Expansion Of Cd4(+) Regulatory T Cells

BML-111 Attenuates Hemorrhagic Shock-Induced Acute Lung Injury Through Inhibiting Activation of Mitogen-Activated Protein Kinase Pathway in Rats.

Late Breaking Abstract - Endothelial Cell-Specific Anticoagulation Reduces Inflammation in a Mouse Model of ALI

Effect of TLR-4 and HO-1 on Acute Lung Injury Induced by Hemorrhagic Shock in Mice

TOLL-LIKE RECEPTOR 4 REGULATES HEME OXYGENASE-1 EXPRESSION AFTER HEMORRHAGIC SHOCK INDUCED ACUTE LUNG INJURY IN MICE

BML-111, a Lipoxin Receptor Agonist, Protects Haemorrhagic Shock-Induced Acute Lung Injury in Rats.

Lipoxin Receptor Agonist, May Be a Potential Treatment for Hemorrhagic Shock-Induced Acute Lung Injury

Inhibition of Peptidylarginine Deiminase Attenuates Inflammation and Improves Survival in A Rat Model of Hemorrhagic Shock

Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury In Vivo and In Vitro Through the PIP2/NF-κB/NLRP3 Signaling Pathway

Role of high mobility group box1 in hemorrhagic shock-induced acute lung injury

Effect of BML-111 on NF-κB Pathway During Acute Lung Injury Induced by Hemorrhagic Shock and Resuscitation in Rats